People · Operator

Eric Carter, Ph.D., M.D.

Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology

1
Companies
1
Filings
$9.2M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Visgenx, Inc.BiotechnologySeries A$9.2M$24.5M2023
Operator network

Eric Carter, Ph.D., M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Arthur Becker · 3 companies · 1 sharedArthur BeckerFrank Douglas · 2 companies · 1 sharedFrank DouglasSantosh Vetticaden · 2 companies · 1 sharedSantosh VetticadenWilliam Pedranti · 2 companies · 1 sharedWilliam PedrantiElaine Heron, Ph.D. · 1 companies · 1 sharedElaine Heron, Ph.…Frank Douglas, M.D., Ph.D. · 1 companies · 1 sharedFrank Douglas, M.…Martin Emanuele · 1 companies · 1 sharedMartin EmanueleMartin Emanuele, Ph.D. · 1 companies · 1 sharedMartin Emanuele, …Santosh Vetticaden, M.D., Ph.D., MBA · 1 companies · 1 sharedSantosh Vetticade…Santosh Vetticaden, Ph.D., M.D. · 1 companies · 1 sharedSantosh Vetticade…Thomas Meier, Ph.D., M.D. · 1 companies · 1 sharedThomas Meier, Ph.…Visgenx, Inc. · $9.2M raisedVisgenx, Inc.Eric Carter, Ph.D., M.D.EM
Eric Carter, Ph.D., M.D. Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Eric Carter, Ph.D., M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Arthur Becker13
William Pedranti12
Santosh Vetticaden12
Frank Douglas12
Thomas Meier, Ph.D., M.D.11
Elaine Heron, Ph.D.11
Santosh Vetticaden, Ph.D., M.D.11
Santosh Vetticaden, M.D., Ph.D., MBA11
Frank Douglas, M.D., Ph.D.11
Martin Emanuele11
Martin Emanuele, Ph.D.11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.